Activist investor Starboard Value, which in recent months has taken stakes in coffee chain Starbucks (SBUX) and pharmaceutical giant Pfizer (PFE), has set its sights on Kenvue (KVUE). The Wall Street Journal reported Starboard taking a "sizable stake" in the Tylenol and Band-Aids maker and hopes to boost its stock price. Shares move higher in Monday's pre-market trading.

Morning Brief anchors Madison Mills and Seana Smith report more on this development for the consumer health product brand. Kenvue spun off from Johnson & Johnson (JNJ) in 2023.

To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

This post was written by Luke Carberry Mogan.